Home > Safety > Interaction And Depletions > Dietary Supplementation (Consumer) > How Coenzyme Q10 (CO-Q10) interacts with Tricyclic antidepressants

How Coenzyme Q10 (CO-Q10) interacts with Tricyclic antidepressants

Interaction type:
Depletions

Interaction rating:
Study Supported

These medications have been reported to decrease the formation of coenzyme-Q10 in the body. Supplementation with the affected nutrient may be necessary. (1) These drugs include amitriptyline, amoxapine,clomipramine, desipramine,doxepin, imipramine, nortriptyline, protryptiline, trimipramine.

References

Kishi T, et al. Inhibition of Myocardial Respiration by Psychotherapeutic Drugs and Prevention by Coenzyme Q10. In: Yamamura Y, Folkers K, Ito Y, eds. Biomedical and Clinical Aspects of Coenzyme Q10. Vol. 2. Amsterdam: Elsevier/North-Holland Biomedical Press;1980:139-54.

In This Scope

Background

COVID-19

Interactions and Depletions

QUICK LINKS

Contact Information

GlobinMed Secretariat,
Integrative Health Information Unit
(Unit Informasi Kesihatan Integratif),

Herbal Medicine Research Center,

Institute for Medical Research,

Block C, National Institutes of Health (NIH),

No.1, Jalan Setia Murni u13/52,

Seksyen U13, Bandar Setia Alam,

40170 Shah Alam, Selangor

Tel: +603-33627657
Email: [email protected]

Disclaimer

The Government of Malaysia and Institute for Medical Research (IMR) shall not be liable for any loss or damage caused by the usage of any information obtained from this web site.